MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/ejhf/xuag022

Медицинская библиотека · European journal of heart failure · 2026

Subclinical atrial fibrillation and the risk of heart failure: insights from ARTESiA.

Frausing Maria Hee Jung Park, McIntyre William F, Healey Jeff S, Kovalova Tanya, Wong Jorge A, Diederichsen Søren Zöga, Xing Lucas Yixi, Granger Christopher B, Lopes Renato D, Benz Alexander P, Erath Julia W, Boriani Giuseppe, Mabo Philippe, Linde Cecilia, Wright David J, Kutyifa Valentina, Birnie David H, Benezet-Mazuecos Juan, Albertsen Andi E, Holm Katja Fiedler, Andrade Jason G, Nielsen Jens Cosedis

СтатьяПеревод в очереди

Аннотация

AIMS: Heart failure (HF) and clinical atrial fibrillation are closely linked, but the relationship between device-detected subclinical atrial fibrillation (SCAF) and HF is unclear. We aimed to determine incidence and clinical risk factors for HF events among patients with SCAF.

METHODS

We included 3986 patients from the ARTESiA (Apixaban for the Reduction of Thromboembolism in Patients with Device-Detected Subclinical Atrial Fibrillation) trial. ARTESiA investigated the effect of apixaban versus aspirin for stroke prevention in patients with episodes of SCAF ≤24 hours. In this secondary analysis, we explored the number and duration of SCAF episodes at baseline as risk markers for HF hospitalization or HF-related death. SCAF progression was analysed as a time-dependent covariate and defined as the development of SCAF >24 hours or clinical atrial fibrillation.

RESULTS

Over a mean follow-up of 4.1 ± 1.7 years, SCAF progression was observed in 1244 patients (31%). Heart failure hospitalization or HF-related death occurred in 515 (13%) patients at a rate of 3.3 [95% confidence interval (CI) 3.1-3.6] per 100 person-years. A total of 172 HF-related events occurred after SCAF progression (7.2 events, 95% CI 6.2-8.3, per 100 PY). SCAF progression was an independent risk factor for HF hospitalization or HF-related death (hazard ratio 2.72, 95% CI 2.24-3.31).

CONCLUSION

Heart failure hospitalization and HF-related death are common in patients with SCAF. Progression to longer SCAF episodes or clinical AF were associated with HF events, but episodes <24 h were not. These findings underscore the need for close surveillance of SCAF patients to detect complications and potentially improve outcomes.

Для цитирования: Frausing Maria Hee Jung Park, McIntyre William F, Healey Jeff S, Kovalova Tanya, Wong Jorge A, Diederichsen Søren Zöga, Xing Lucas Yixi, Granger Christopher B, Lopes Renato D, Benz Alexander P, Erath Julia W, Boriani Giuseppe, Mabo Philippe, Linde Cecilia, Wright David J, Kutyifa Valentina, Birnie David H, Benezet-Mazuecos Juan, Albertsen Andi E, Holm Katja Fiedler, Andrade Jason G, Nielsen Jens Cosedis. Subclinical atrial fibrillation and the risk of heart failure: insights from ARTESiA.. European journal of heart failure. 2026. DOI: 10.1093/ejhf/xuag022.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.